Free Trial

Park Dental Partners (PARK) Competitors

$18.54 -0.04 (-0.21%)
As of 05/22/2026 04:00 PM Eastern
This is a fair market value price provided by Massive. Learn more.

PARK vs. SBC, LFMD, BNR, BDSX, and NAKA

Should you buy Park Dental Partners stock or one of its competitors? MarketBeat compares Park Dental Partners with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Park Dental Partners include SBC Medical Group (SBC), LifeMD (LFMD), Burning Rock Biotech (BNR), Biodesix (BDSX), and KindlyMD (NAKA). These companies are all part of the "healthcare" industry.

How does Park Dental Partners compare to SBC Medical Group?

Park Dental Partners (NASDAQ:PARK) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

60.8% of SBC Medical Group shares are held by institutional investors. 10.6% of Park Dental Partners shares are held by insiders. Comparatively, 89.5% of SBC Medical Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Park Dental Partners had 2 more articles in the media than SBC Medical Group. MarketBeat recorded 8 mentions for Park Dental Partners and 6 mentions for SBC Medical Group. Park Dental Partners' average media sentiment score of 0.65 beat SBC Medical Group's score of 0.64 indicating that Park Dental Partners is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SBC Medical Group
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

SBC Medical Group has lower revenue, but higher earnings than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Park Dental Partners$244.49M0.34N/AN/AN/A
SBC Medical Group$173.61M1.81$50.99M$0.397.87

Park Dental Partners currently has a consensus price target of $21.75, suggesting a potential upside of 17.06%. SBC Medical Group has a consensus price target of $8.50, suggesting a potential upside of 176.87%. Given SBC Medical Group's higher possible upside, analysts plainly believe SBC Medical Group is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Park Dental Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
3 Strong Buy rating(s)
3.25
SBC Medical Group
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

SBC Medical Group has a net margin of 24.09% compared to Park Dental Partners' net margin of 0.00%. SBC Medical Group's return on equity of 15.90% beat Park Dental Partners' return on equity.

Company Net Margins Return on Equity Return on Assets
Park Dental PartnersN/A N/A N/A
SBC Medical Group 24.09%15.90%11.61%

Summary

SBC Medical Group beats Park Dental Partners on 8 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to LifeMD?

LifeMD (NASDAQ:LFMD) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations.

LifeMD presently has a consensus target price of $9.14, suggesting a potential upside of 118.21%. Park Dental Partners has a consensus target price of $21.75, suggesting a potential upside of 17.06%. Given LifeMD's higher probable upside, equities research analysts clearly believe LifeMD is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeMD
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67
Park Dental Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
3 Strong Buy rating(s)
3.25

LifeMD has higher earnings, but lower revenue than Park Dental Partners.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeMD$194.05M1.04$14.35M$0.0583.80
Park Dental Partners$244.49M0.34N/AN/AN/A

In the previous week, Park Dental Partners had 8 more articles in the media than LifeMD. MarketBeat recorded 8 mentions for Park Dental Partners and 0 mentions for LifeMD. Park Dental Partners' average media sentiment score of 0.65 beat LifeMD's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company Overall Sentiment
LifeMD Neutral
Park Dental Partners Positive

35.5% of LifeMD shares are owned by institutional investors. 18.4% of LifeMD shares are owned by insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

LifeMD has a net margin of 2.37% compared to Park Dental Partners' net margin of 0.00%. Park Dental Partners' return on equity of 0.00% beat LifeMD's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeMD2.37% -150.88% -22.59%
Park Dental Partners N/A N/A N/A

Summary

Park Dental Partners beats LifeMD on 7 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to Burning Rock Biotech?

Burning Rock Biotech (NASDAQ:BNR) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

30.0% of Burning Rock Biotech shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by company insiders. Comparatively, 10.6% of Park Dental Partners shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Park Dental Partners has a consensus price target of $21.75, indicating a potential upside of 17.06%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts plainly believe Park Dental Partners is more favorable than Burning Rock Biotech.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Burning Rock Biotech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Park Dental Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
3 Strong Buy rating(s)
3.25

Park Dental Partners has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -10.27%. Park Dental Partners' return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
Burning Rock Biotech-10.27% -9.98% -6.69%
Park Dental Partners N/A N/A N/A

Park Dental Partners has higher revenue and earnings than Burning Rock Biotech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Burning Rock Biotech$77.16M1.98-$7.92M-$0.79N/A
Park Dental Partners$244.49M0.34N/AN/AN/A

In the previous week, Park Dental Partners had 8 more articles in the media than Burning Rock Biotech. MarketBeat recorded 8 mentions for Park Dental Partners and 0 mentions for Burning Rock Biotech. Park Dental Partners' average media sentiment score of 0.65 beat Burning Rock Biotech's score of 0.00 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company Overall Sentiment
Burning Rock Biotech Neutral
Park Dental Partners Positive

Summary

Park Dental Partners beats Burning Rock Biotech on 9 of the 12 factors compared between the two stocks.

How does Park Dental Partners compare to Biodesix?

Biodesix (NASDAQ:BDSX) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

Park Dental Partners has higher revenue and earnings than Biodesix.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$88.50M1.71-$35.26M-$4.06N/A
Park Dental Partners$244.49M0.34N/AN/AN/A

Biodesix presently has a consensus target price of $22.00, suggesting a potential upside of 47.35%. Park Dental Partners has a consensus target price of $21.75, suggesting a potential upside of 17.06%. Given Biodesix's higher probable upside, research analysts plainly believe Biodesix is more favorable than Park Dental Partners.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33
Park Dental Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
3 Strong Buy rating(s)
3.25

Park Dental Partners has a net margin of 0.00% compared to Biodesix's net margin of -33.26%. Park Dental Partners' return on equity of 0.00% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-33.26% -2,101.40% -35.65%
Park Dental Partners N/A N/A N/A

21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by insiders. Comparatively, 10.6% of Park Dental Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Park Dental Partners had 6 more articles in the media than Biodesix. MarketBeat recorded 8 mentions for Park Dental Partners and 2 mentions for Biodesix. Biodesix's average media sentiment score of 0.92 beat Park Dental Partners' score of 0.65 indicating that Biodesix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biodesix
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Park Dental Partners beats Biodesix on 7 of the 13 factors compared between the two stocks.

How does Park Dental Partners compare to KindlyMD?

KindlyMD (NASDAQ:NAKA) and Park Dental Partners (NASDAQ:PARK) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability.

KindlyMD presently has a consensus target price of $0.75, suggesting a potential downside of 89.63%. Park Dental Partners has a consensus target price of $21.75, suggesting a potential upside of 17.06%. Given Park Dental Partners' stronger consensus rating and higher probable upside, analysts plainly believe Park Dental Partners is more favorable than KindlyMD.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
KindlyMD
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Park Dental Partners
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
3 Strong Buy rating(s)
3.25

Park Dental Partners has higher revenue and earnings than KindlyMD.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
KindlyMD$1.82M69.12-$52.23M-$43.20N/A
Park Dental Partners$244.49M0.34N/AN/AN/A

Park Dental Partners has a net margin of 0.00% compared to KindlyMD's net margin of -7,397.12%. Park Dental Partners' return on equity of 0.00% beat KindlyMD's return on equity.

Company Net Margins Return on Equity Return on Assets
KindlyMD-7,397.12% -81.32% -54.17%
Park Dental Partners N/A N/A N/A

In the previous week, Park Dental Partners had 1 more articles in the media than KindlyMD. MarketBeat recorded 8 mentions for Park Dental Partners and 7 mentions for KindlyMD. Park Dental Partners' average media sentiment score of 0.65 beat KindlyMD's score of -0.27 indicating that Park Dental Partners is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
KindlyMD
0 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Park Dental Partners
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Park Dental Partners beats KindlyMD on 9 of the 11 factors compared between the two stocks.

Get Park Dental Partners News Delivered to You Automatically

Sign up to receive the latest news and ratings for PARK and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PARK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PARK vs. The Competition

MetricPark Dental PartnersServices – Health IndustryServices SectorNASDAQ Exchange
Market Cap$83.89M$1.43B$978.18M$12.34B
Dividend YieldN/AN/A5.12%5.28%
P/E RatioN/A13.099.1225.65
Price / Sales0.345.2336.5386.28
Price / CashN/A3,138.58381.8256.67
Price / BookN/A4.444.357.14
Net IncomeN/A-$26.94M-$6.42M$335.98M
7 Day Performance-1.12%1.35%3.07%4.15%
1 Month Performance1.98%-5.43%-5.06%2.54%
1 Year PerformanceN/AN/A48.28%35.05%

Park Dental Partners Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PARK
Park Dental Partners
3.1341 of 5 stars
$18.58
flat
$21.75
+17.1%
N/A$83.89M$244.49MN/A1,208
SBC
SBC Medical Group
4.4442 of 5 stars
$2.87
-3.4%
$8.50
+196.2%
-32.5%$304.65M$173.61M7.36N/A
LFMD
LifeMD
3.0942 of 5 stars
$4.24
-2.1%
$9.14
+115.6%
-63.7%$209.41M$194.05M84.82230
BNR
Burning Rock Biotech
1.1091 of 5 stars
$16.93
-0.7%
N/A+342.4%$179.23M$77.16MN/A1,390
BDSX
Biodesix
3.8482 of 5 stars
$14.25
+0.6%
$31.00
+117.5%
+117.9%$143.24M$88.50MN/A220

Related Companies and Tools


This page (NASDAQ:PARK) was last updated on 5/26/2026 by MarketBeat.com Staff.
From Our Partners